These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 28794139

  • 1. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM.
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [Abstract] [Full Text] [Related]

  • 2. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.
    Fallavollita JA, Heavey BM, Luisi AJ, Michalek SM, Baldwa S, Mashtare TL, Hutson AD, Dekemp RA, Haka MS, Sajjad M, Cimato TR, Curtis AB, Cain ME, Canty JM.
    J Am Coll Cardiol; 2014 Jan 21; 63(2):141-9. PubMed ID: 24076296
    [Abstract] [Full Text] [Related]

  • 3. Impact of denervated myocardium on improving risk stratification for sudden cardiac death.
    Cain ME.
    Trans Am Clin Climatol Assoc; 2014 Jan 21; 125():141-53; discussion 153. PubMed ID: 25125727
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L, Pasceri V, Mollica C, Ficili S, Poti G, Aquilani S, Santini M, La Rocca S.
    J Cardiovasc Med (Hagerstown); 2011 May 21; 12(5):334-9. PubMed ID: 21487343
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G, Guaricci AI, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Fusini L, Rota C, Segurini C, Conte E, Gripari P, Dello Russo A, Moltrasio M, Tundo F, Lombardi F, Muscogiuri G, Lorenzoni V, Tondo C, Agostoni P, Bartorelli AL, Pepi M.
    Circ Cardiovasc Imaging; 2016 Oct 21; 9(10):. PubMed ID: 27729359
    [Abstract] [Full Text] [Related]

  • 6. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
    Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E, Lima JA, Tomaselli GF, Weiss RG.
    Circ Cardiovasc Imaging; 2012 Mar 21; 5(2):178-86. PubMed ID: 22267750
    [Abstract] [Full Text] [Related]

  • 7. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N, Boveda S, Defaye P, Klug D, Treguer F, Amet D, Perier MC, Gras D, Algalarrondo V, Bouzeman A, Piot O, Deharo JC, Fauchier L, Babuty D, Bordachar P, Sadoul N, Marijon E, Leclercq C, DAI-PP Investigators.
    Europace; 2018 Jan 01; 20(1):65-72. PubMed ID: 28082419
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS, Ruwald AC, Kutyifa V, Ruwald MH, Mcnitt S, Polonsky B, Goldstein RE, Haigney MC, Krone RJ, Zareba W, Moss AJ, MADIT-CRT Investigators.
    Europace; 2015 Dec 01; 17(12):1816-22. PubMed ID: 26071234
    [Abstract] [Full Text] [Related]

  • 9. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
    Elming MB, Nielsen JC, Haarbo J, Videbæk L, Korup E, Signorovitch J, Olesen LL, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Køber L, Thune JJ.
    Circulation; 2017 Nov 07; 136(19):1772-1780. PubMed ID: 28877914
    [Abstract] [Full Text] [Related]

  • 10. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G.
    Circ Cardiovasc Qual Outcomes; 2015 Mar 07; 8(2):179-86. PubMed ID: 25669833
    [Abstract] [Full Text] [Related]

  • 11. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ.
    Circ Arrhythm Electrophysiol; 2016 Mar 07; 9(3):e003283. PubMed ID: 26921377
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action.
    Katritsis DG, Zografos T, Hindricks G.
    Europace; 2018 Sep 01; 20(FI2):f148-f152. PubMed ID: 29236981
    [Abstract] [Full Text] [Related]

  • 13. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S, Asad Z, Reynolds D.
    J Cardiovasc Electrophysiol; 2017 Jun 01; 28(6):659-665. PubMed ID: 28316104
    [Abstract] [Full Text] [Related]

  • 14. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S, Duehmke R, Providencia R, Marijon E, Boveda S, Virdee M, Heck P, Fynn S, Begley D, Grace A, Agarwal S.
    Europace; 2018 Jan 01; 20(1):89-96. PubMed ID: 28031276
    [Abstract] [Full Text] [Related]

  • 15. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, Rivero-Ayerza M, Tang WH, Mullens W.
    Heart; 2017 Dec 01; 103(24):1977-1984. PubMed ID: 28716973
    [Abstract] [Full Text] [Related]

  • 16. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A, Zhang Y, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF.
    Circ Arrhythm Electrophysiol; 2014 Dec 01; 7(6):1084-91. PubMed ID: 25273351
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of discordant T waves in lead aVR: A simple risk marker of sudden cardiac arrest in ischemic cardiomyopathy.
    Al-Zaiti SS, Fallavollita JA, Canty JM, Carey MG.
    J Electrocardiol; 2015 Dec 01; 48(5):887-92. PubMed ID: 26233648
    [Abstract] [Full Text] [Related]

  • 18. Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy.
    Zelt JGE, Wang JZ, Mielniczuk LM, Beanlands RSB, Fallavollita JA, Canty JM, deKemp RA.
    Circ Cardiovasc Imaging; 2021 Jun 01; 14(6):e012549. PubMed ID: 34102857
    [Abstract] [Full Text] [Related]

  • 19. Comparable survival in ischemic and nonischemic cardiomyopathy secondary to ventricular tachyarrhythmias and aborted cardiac arrest.
    Rusnak J, Behnes M, Schupp T, Weiß C, Nienaber C, Lang S, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Ansari U, El-Battrawy I, Bertsch T, Akin M, Mashayekhi K, Borggrefe M, Akin I.
    Coron Artery Dis; 2019 Jun 01; 30(4):303-311. PubMed ID: 30896453
    [Abstract] [Full Text] [Related]

  • 20. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG, Kwong RY, John RM, van der Geest RJ, Tao Q, Schaeffer B, Tanigawa S, Nakamura T, Kaneko K, Tedrow UB, Stevenson WG, Epstein LM, Kapur S, Zei PC, Koplan BA.
    JACC Cardiovasc Imaging; 2019 Jul 01; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.